# Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

> **NCT04385836** · EARLY_PHASE1 · UNKNOWN · sponsor: **Ministry of Health, Saudi Arabia** · enrollment: 150 (estimated)

## Conditions studied

- Coronavirus

## Interventions

- **DRUG:** alpha one antitrypsin inhalation

## Key facts

- **NCT ID:** NCT04385836
- **Lead sponsor:** Ministry of Health, Saudi Arabia
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-01
- **Primary completion:** 2020-09-01
- **Final completion:** 2020-09-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2020-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04385836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04385836, "Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04385836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*